Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial
Authors:
- 24 February 2023
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 260, 18-25
Abstract
No abstract availableKeywords
Funding Information
- Tsumura & CO
This publication has 36 references indexed in Scilit:
- Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin–angiotensin–aldosterone system in ratsJournal of Ethnopharmacology, 2012
- Effects of Gorei-san: A Traditional Japanese Kampo Medicine, on Aquaporin 1, 2, 3, 4 and V2R mRNA Expression in Rat Kidney and ForebrainJournal of Medical Sciences, 2010
- Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalizationAmerican Heart Journal, 2010
- The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescriptionJournal of Ethnopharmacology, 2009
- Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicineFood and Chemical Toxicology, 2008
- Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practiceInternational Journal of Cardiology, 2008
- Traditional Chinese Medicine and Kampo: A Review from the Distant past for the FutureJournal of International Medical Research, 2006
- Survival after the onset of congestive heart failure in Framingham Heart Study subjects.Circulation, 1993
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.Heart, 1987